Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Zai Lab Ltd ADR (ZLAB)

Zai Lab Ltd ADR (ZLAB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,629,486
  • Shares Outstanding, K 97,909
  • Annual Sales, $ 144,310 K
  • Annual Income, $ -704,470 K
  • 60-Month Beta 1.20
  • Price/Sales 24.96
  • Price/Cash Flow N/A
  • Price/Book 2.71
Trade ZLAB with:

Options Overview Details

View History
  • Implied Volatility 91.71% ( +5.53%)
  • Historical Volatility 117.34%
  • IV Percentile 92%
  • IV Rank 65.39%
  • IV High 117.60% on 03/14/22
  • IV Low 42.77% on 06/25/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 0.75
  • Today's Open Interest 2,146
  • Open Int (30-Day) 2,499

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.94
  • Number of Estimates 3
  • High Estimate -0.90
  • Low Estimate -1.01
  • Prior Year -1.76
  • Growth Rate Est. (year over year) +46.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.50 +38.98%
on 05/11/22
46.05 -26.06%
on 04/25/22
-9.34 (-21.53%)
since 04/22/22
3-Month
24.50 +38.98%
on 05/11/22
56.06 -39.26%
on 02/28/22
-21.20 (-38.37%)
since 02/24/22
52-Week
24.50 +38.98%
on 05/11/22
181.92 -81.28%
on 06/02/21
-128.59 (-79.06%)
since 05/24/21

Most Recent Stories

More News
Zai Lab Announces Upcoming Presentations at June Investor Conferences

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused,...

ZLAB : 34.05 (-8.15%)
Zai Lab Announces Change to Virtual 2022 Annual General Meeting of Shareholders to be Held on June 22, 2022

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused,...

ZLAB : 34.05 (-8.15%)
Zai Lab Partner argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia

- Study met primary endpoint, demonstrating a higher proportion of sustained platelet response with VYVGART treatment compared to placebo (p=0.0316);...

ZLAB : 34.05 (-8.15%)
Zai Lab and Turning Point Therapeutics Announce Topline Analysis in China Subpopulation for Repotrectinib in ROS1-Positive NSCLC Cohorts Within Global Phase 1/2 TRIDENT-1 Study

91% confirmed objective response rate (cORR) (10/11) in China subpopulation by Blinded Independent Central Review (BICR) in TKI-naïve cohort (EXP-1) In...

ZLAB : 34.05 (-8.15%)
TPTX : 33.26 (-9.35%)
Zai Lab Announces Engagement of KPMG LLP, a U.S. Auditor, as the Company’s Independent Registered Public Accounting Firm

Zai Lab’s engagement of an audit firm located in the United States is expected to facilitate the Company’s continued listing on Nasdaq because KPMG is...

ZLAB : 34.05 (-8.15%)
Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022

-- Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET...

ZLAB : 34.05 (-8.15%)
Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting

-  First preview of preclinical data for ZL-1218, an anti-CCR8 antibody, in an oral presentation -  Poster presentations will feature three additional...

ZLAB : 34.05 (-8.15%)
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Zai Lab Limited with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zai Lab Limited (“Zai Lab” or “the Company”) (NASDAQ: ZLAB...

ZLAB : 34.05 (-8.15%)
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Zai Lab Limited with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zai Lab Limited (“Zai Lab” or “the Company”) (NASDAQ: ZLAB...

ZLAB : 34.05 (-8.15%)
EQUITY ALERT: Rosen Law Firm Encourages Zai Lab Limited Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – ZLAB

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zai Lab Limited (NASDAQ: ZLAB) resulting from allegations...

ZLAB : 34.05 (-8.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China....

See More

Key Turning Points

3rd Resistance Point 38.85
2nd Resistance Point 37.56
1st Resistance Point 35.81
Last Price 34.05
1st Support Level 32.76
2nd Support Level 31.48
3rd Support Level 29.72

See More

52-Week High 181.92
Fibonacci 61.8% 121.79
Fibonacci 50% 103.21
Fibonacci 38.2% 84.63
Last Price 34.05
52-Week Low 24.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar